Gianluca Ingrosso

18PUBLICATIONS
27CO-AUTHORS
Molecular targetsInstruments and techniquesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 19, 2026
Novel biomarkers driving treatment selection in metastatic castration-sensitive prostate cancer: fundamentals of personalized clinical decision making.

|Apr 06, 2026
Moderate hypofractionation: long-term toxicity results of prostate bed radiotherapy (FRAME-PROSTATE).

Federico Camilli, Saverio Caini, Chiara Doccioli

|Aug 27, 2025
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.

Lilia Bardoscia, Angela Sardaro, Mariagrazia Quattrocchi

|Aug 01, 2025
Ablative radiotherapy for polymetastatic disease: a new kid on the block.

Federico Camilli, Andrea Lancia, Sheetal R Kashid

|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.

Gianluca Ingrosso, Andrea Lancia, Lilia Bardoscia

|Mar 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.

Gianluca Ingrosso, Eleonora Festa, Saverio Caini

Pageof 3

Frequent Collaborators

6 joint publications

Andrea Lancia

4 joint publications

Giulio Francolini

3 joint publications

Cynthia Aristei

3 joint publications

Alessio Bruni